Table 2.
Effect of NCE treatment on cerebral antioxidant enzymes activities Values are shown as the mean ± SD of 7 mice in each group. Tukey’s Post hoc test was used to compare between groups.
| Groups | CAT (U/mg protein) | SOD (% inhibition) | GRx (U/mg protein) |
|---|---|---|---|
| Control | 144.82 ± 18.28 | 97.09 ± 1.62 | 132.86 ± 23.30 |
| NCE 150 | 154.28 ± 15.79 | 94.85 ± 2.89 | 126.64 ± 20.69 |
| SCZ | 68.91 ± 11.89 *** | 59.29 ± 6.70 *** | 54.12 ± 11.62 *** |
| ARI | 130.61 ± 30.10 +++ | 88.71 ± 11.46 +++ | 114.82 ± 15.27 +++ |
| KET + NCE 70 | 52.19 ± 20.95 *** | 68.97 ± 7.73 *** | 88.07 ± 19.58 ** + |
| KET + NCE0 150 | 117.24 ± 21.31 ++ | 84.35 ± 13.21 ++ | 130.50 ± 19.95 +++ |
SCZ; schizophrenia, ARI; aripiprazole, NCE (Nostoc commune extract) 70 and 150 mg/kg**P < 0.01, ***P < 0.001 as compared to the control group;+P<0.05, ++ P<0.01, +++ P<0.001 as compared to SCZ group.